Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study - Concepedia

Concepedia

Publication | Open Access

Ruxolitinib Therapy Followed by Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study

DOI Full Paper Access

58

Citations

24

References

2018

Year

Vikas Gupta, Heidi Kosiorek, Adam J. Mead, Rebecca B. Klisovic, John P. Galvin, Dmitriy Berenzon, Abdulraheem Yacoub, Auro Viswabandya, Ruben A. Mesa, Judith D. Goldberg,

Biology of Blood and Marrow Transplantation

References

	Year	Citations

Page 1